ANDA 202010, held by Ph Health. Tamsulosin Hydrochloride.
As of Nov 15, 2026, ANDA 202010 (Tamsulosin Hydrochloride), held by Ph Health, was first approved by FDA on Jan 4, 2013, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 4, 2013 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tamsulosin Hydrochloride0.4MG · capsule;oral | Tamsulosin Hydrochloride | Discontinued |
| Nov 16, 2015 | Supplement 2Labeling · Standard review | Approved | None posted |
| Nov 16, 2015 | Supplement 5Labeling · Standard review | Approved | None posted |
| Jan 4, 2013 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters